Search

Your search keyword '"Van Poppel, H"' showing total 1,746 results

Search Constraints

Start Over You searched for: Author "Van Poppel, H" Remove constraint Author: "Van Poppel, H"
1,746 results on '"Van Poppel, H"'

Search Results

1. Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

2. Understanding the barriers to prostate cancer population-based early detection programs: The PRAISE-U BEST survey

3. Natural history of pN1 prostate cancer after radical prostatectomy: Competing risk analysis from a large multi-institutional series

4. Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

5. Correlation between the location of the index tumour and the location of positive lymph nodes in high-risk prostate cancer – a monocentric positive lymph node mapping study

6. Developing and comparing prostate cancer screening specific performance indicators for PRAISE-U

7. Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

8. Why is there a need to re-think prostate cancer early detection?

9. Oncologic outcomes of template vs. radio-guided salvage lymph node dissection for node-only recurrent prostate cancer: Results from a multi-institutional collaboration

11. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

13. Tumoren van de urinewegen

14. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer

16. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics

17. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool

18. Toxicity profile of immediate post-prostatectomy radiation therapy: results from a large multi-institutional series

19. What is the optimal management of nodal oligorecurrent prostate cancer? results from a large series of patients treated with salvage lymph node dissection

20. Oncological outcomes, patterns of recurrence and impact of competing causes of mortality in clinically node-positive prostate cancer patients treated with radical prostatectomy

21. E-book: Screening - Uitgave 2022

24. E-book: Oncologie 2021 - 2022

27. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer

28. Palliative Surgical Therapy

29. Nephron-Sparing Surgery

31. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics

32. Prognostic impact of clear cell renal cell carcinoma molecular subtypes determined on formalin-fixed paraffin-embedded tissue samples on outcome after complete surgical metastasectomy

33. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: A novel risk stratification tool

34. PSA doubling time as predictor of relapse after early salvage radiation therapy: When should imaging be used to select patients who might not benefit from early local treatments?

35. Update on the management of invasive bladder cancer 2012

36. Long-term Results of Brachytherapy with Iridium-192 Implants

37. Complications of Radical Cystectomy

38. Prophylactic Urethrectomy: When and How?

39. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?

40. Chemoprevention of prostate cancer with nutrients and supplements

41. Hyperthermia for Carcinoma of the Prostate

42. Surgical Treatment of Carcinoma of the Prostate

43. Complications of Radical Prostatectomy

45. Patterns of Failure in Surgically Treated Patients

46. The key role of PSA doubling time in patients treatedwith salvage radiation therapy after radical prostatectomy: implications for the extent of radiation and the concomitant use of hormonal therapy

47. Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treatedwith post-prostatectomy radiation therapy: results from a large, multi-institutional study

48. Very long term outcomes, time patterns of recurrence and other-cause mortality in patients treated with salvage radiation therapy for recurrent prostate cancer after radical prostatectomy: implications for risk tailored follow-up strategies

49. What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 prostate cancer? Results form a large multi-institutional series

50. PET/CT allows for a reliable assessment of the real nodal burden in clinically node-positive prostate cancer patients candidate for radical prostatectomy: results from a multi-institutional series

Catalog

Books, media, physical & digital resources